atl v1.0.5

Zantac Cancer Risk: Drug Pulled From Stores

Attorney Jeffrey Phillips | 800-260-0800 | Free Consult

Have you ever taken the drug Zantac? You should know that the FDA has ordered makers of the drug to stop selling it in stores. The World Health Organization says that Zantac contains a contaminant called NDMA that poses a cancer risk to users.

This Legal Brief features attorney Jeffrey Phillips of Phillips Law Group in Phoenix, Arizona. He explains that the Zantac cancer risk led to the drug being removed from the shelves.

To learn more, contact the attorney directly by calling 800-260-0800 or by submitting a contact form on this page. The consultation is free and confidential, and you owe no out-of-pocket attorney fees.

Zantac and other heartburn medications containing NDMA have been linked to certain cancers.

Zantac, a popular heartburn medication previously marketed as safe and effective, has recently been proven to include a probable human carcinogen. Not only Zantac but similar heartburn medications containing a contaminant known as NDMA have been shown to pose significant cancer risk to users.
According to Drug Watch, stomach, liver, and bladder cancers make up just three of the types of cancer currently linked to the use of Zantac and similar heartburn medications. Additionally, NDMA has proven to have potential negative effects on the bladder, brain, liver, kidneys, lungs, and stomach. Research is still being conducted to see if other cancers and/or health issues might be linked to NDMA.

The Food and Drug Administration (FDA) has ordered Zantac and equivalent drugs be removed from shelves and for consumers to cease using it immediately.

Zantac and all similar drugs containing NDMA have been ordered to be removed from shelves in light of the new discoveries regarding their harmful properties. Research has shown that the impurity in these medications increases with time, possibly due to temperature and other conditions in which it is stored. These medications should no longer be prescribed or sold over-the-counter.

Additionally, the FDA advises consumers to immediately cease using Zantac and other drugs containing NDMA in favor of other heartburn medications which have not been proven to pose these health risks.

If you have been diagnosed with cancer and were a frequent user of Zantac, seek legal counsel.

Lawsuits have already been filed against the manufacturer of Zantac on behalf of the long-time users of this drug who developed cancer as a result. If you have been diagnosed with cancer and suspect your cancer might be linked to frequent or long-time use of Zantac, seek legal counsel to discover what your rights are as well as how you can seek compensation for medical bills and other damages you might have sustained as a result of using this medication.

To learn more, contact Jeffrey Phillips directly by calling 800-260-0800 or by submitting a contact form on this page. The consultation is free and confidential, and you owe no out-of-pocket attorney fees.

Video Transcript:

What does the removal of the drug Zantac from stores mean for you?

I'm Rob Rosenthal and this is an AskTheLawyers.com™ Legal Brief.

The Food and Drug Administration is telling manufacturers of the drug known by the brand name Zantac to immediately pull it from the stores.

This includes prescription and over-the-counter versions of the heartburn medication. The move comes after the FDA has determined Zantac could contain a contaminant in levels high enough to pose a risk to public health. The World Health Organization says that a contaminant known as NDMA is a probable human carcinogen. The FDA is requesting all Zantac-brand products and the generic versions be withdrawn from the market, and consumers are being advised to stop taking any versions of the medication.

Lawsuits have already been filed against the manufacturers of Zantac on behalf of long-term users who have been diagnosed with one of the cancers linked to NDMA. Attorney Jeffrey Phillips of Arizona says:

"This is incredibly disappointing, particularly in light of the fact that this over-the-counter heartburn medication is so widely used and was advertised as safe. Although we applaud the FDA for pulling it from the shelves, it may be too little too late for innocent people who are now facing long-term disease, and cancer, as a result."

He goes on to say: "It's not too late to find out if you qualify to participate in this litigation." The FDA advises consumers who wish to continue treatment for their heartburn take one of the other medications on the market that have been approved and don't carry the risk of NDMA.

This has been an AskTheLawyers.com™ Legal Brief.

Disclaimer: This video is for informational purposes only. In some states, this video may be deemed Attorney Advertising. The choice of lawyer is an important decision that should not be based solely on advertisements.

AskTheLawyers

© 1999-2021 AskTheLawyers.com™

Terms and Conditions / Privacy Policy

Legal Disclaimer: This website is for informational purposes only. Use of this website does not constitute an attorney-client relationship. Information entered on this website is not confidential. This website has paid attorney advertising. Anyone choosing a lawyer must do their own independent research. By using this website, you agree to our additional Terms and Conditions and Privacy Policy.

Send